Authors:
Vertongen, P
Solano, RM
Juarranz, MG
Perret, J
Waelbroeck, M
Robberecht, P
Citation: P. Vertongen et al., Proline residue 280 in the second extracellular loop (EC2) of the VPAC(2) receptor is essential for the receptor structure, PEPTIDES, 22(9), 2001, pp. 1363-1370
Citation: M. Waelbroeck, Activation of guanosine 5 '-[gamma-S-35]thio-triphosphate binding through M-1 muscarinic receptors in transfected Chinese hamster ovary cell membranes: 1. Mathematical analysis of catalytic G protein activation, MOLEC PHARM, 59(4), 2001, pp. 875-885
Citation: M. Waelbroeck, Activation of guanosine 5 '-[gamma-S-35]thio-triphosphate binding through M1 muscarinic receptors in transfected Chinese hamster ovary cell membranes: 2. Testing the "two-states" model of receptor activation, MOLEC PHARM, 59(4), 2001, pp. 886-893
Authors:
Solano, RM
Langer, I
Perret, J
Vertongen, P
Juarranz, MG
Robberecht, P
Waelbroeck, M
Citation: Rm. Solano et al., Two basic residues of the h-VPAC(1) receptor second transmembrane helix are essential for ligand binding and signal transduction, J BIOL CHEM, 276(2), 2001, pp. 1084-1088
Authors:
Vertongen, P
Solano, RM
Perret, J
Langer, I
Robberecht, P
Waelbroeck, M
Citation: P. Vertongen et al., Mutational analysis of the human vasoactive intestinal peptide receptor subtype VPAC(2): role of basic residues in the second transmembrane helix, BR J PHARM, 133(8), 2001, pp. 1249-1254
Authors:
Moreno, D
Gourlet, P
De Neef, P
Cnudde, J
Waelbroeck, M
Robberecht, P
Citation: D. Moreno et al., Development of selective agonists and antagonists for the human vasoactiveintestinal polypeptide VPAC(2) receptor, PEPTIDES, 21(10), 2000, pp. 1543-1549
Authors:
Van Rampelbergh, J
Juarranz, MG
Perret, J
Bondue, A
Solano, RM
Delporte, C
De Neef, P
Robberecht, P
Waelbroeck, M
Citation: J. Van Rampelbergh et al., Characterization of a novel VPAC(1) selective agonist and identification of the receptor domains implicated in the carboxyl-terminal peptide recognition, BR J PHARM, 130(4), 2000, pp. 819-826
Authors:
Di Paolo, E
Petry, H
Moguilevsky, N
Bollen, A
De Neef, P
Waelbroeck, M
Robberecht, P
Citation: E. Di Paolo et al., Mutations of aromatic residues in the first transmembrane helix impair signalling by the secretin receptor, RECEPT CHAN, 6(4), 1999, pp. 309-315
Authors:
Busto, R
Juarranz, MG
De Maria, S
Robberecht, P
Waelbroeck, M
Citation: R. Busto et al., Evidence for multiple rat VPAC(1) receptor states with different affinities for agonists, CELL SIGNAL, 11(9), 1999, pp. 691-696
Authors:
Di Paolo, E
De Neef, P
Moguilevsky, N
Petry, H
Cnudde, J
Bollen, A
Waelbroeck, M
Robberecht, P
Citation: E. Di Paolo et al., Properties of a recombinant human secretin receptor: A comparison with therat and rabbit receptors, PANCREAS, 19(1), 1999, pp. 51-55
Authors:
Di Paolo, E
Vilardaga, JP
Petry, H
Moguilevsky, N
Bollen, A
Robberecht, P
Waelbroeck, M
Citation: E. Di Paolo et al., Role of charged amino acids conserved in the vasoactive intestinal polypeptide/secretin family of receptors on the secretin receptor functionality, PEPTIDES, 20(10), 1999, pp. 1187-1193
Authors:
Juarranz, MG
Van Rampelbergh, J
Gourlet, P
De Neef, P
Cnudde, J
Robberecht, P
Waelbroeck, M
Citation: Mg. Juarranz et al., Different vasoactive intestinal polypeptide receptor domains are involved in the selective recognition of two VPAC(2)-selective ligands, MOLEC PHARM, 56(6), 1999, pp. 1280-1287
Authors:
Juarranz, MG
Van Rampelbergh, J
Gourlet, P
De Neef, P
Cnudde, L
Robberecht, P
Waelbroeck, M
Citation: Mg. Juarranz et al., Vasoactive intestinal polypeptide VPAC(1) and VPAC(2) receptor chimeras identify domains responsible for the specificity of ligand binding and activation, EUR J BIOCH, 265(1), 1999, pp. 449-456